ACLX 66.48 (-0.79%)
US03940C1009BiotechnologyBiotechnology

Arcellx (ACLX) Stock Highlights

66.48 | -0.79%
2025-01-20 02:36:30
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

Statistics

Range Today
65.38 68.16
Volume Today 562.5K
Range 1 Year
47.88 107.37
Volume 1 Year 126.31M
Range 3 Year
6.03 107.37
Volume 3 Year 359.16M
Range 10 Year
6.03 107.37
Volume 10 Year 359.16M

Highlights

Market Capitalization 3.59B (mid)
Floating Shares 35.76M
Current Price 66.48
Price To Earnings -95.85
Price To Revenue 19.8
Price To Book 7.43
Earnings Per Share -0.71
Payout Ratio 0%

Performance

Latest -0.79%
1 Month -19.08%
3 Months -29.8%
6 Months +2.5%
1 Year +23.04%
3 Years +249.89%
5 Years +249.89%
10 Years +249.89%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.